Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
How Lipid Metabolism May Shape Multiple Sclerosis Severity: Genetic Evidence from Mendelian Randomization
Genetics
How Lipid Metabolism May Shape Multiple Sclerosis Severity: Genetic Evidence from Mendelian Randomization

25, Aug 2026

2
How Lipid Metabolism May Shape Multiple Sclerosis Severity: Genetic Evidence from Mendelian Randomization
Genetics
Vitamin D and Genetic Susceptibility to Multiple Sclerosis: A Complex Biological Relationship

24, Aug 2026

3
Metabolic Signatures of Multiple Sclerosis: Uncovering Molecular Clues Through Multi-Omic Analysis
Genetics
Metabolic Signatures of Multiple Sclerosis: Uncovering Molecular Clues Through Multi-Omic Analysis

24, Aug 2026

4
Modeling Metabolic Dynamics for Biomarker Discovery in Multiple Sclerosis
Genetics
Modeling Metabolic Dynamics for Biomarker Discovery in Multiple Sclerosis

23, Aug 2026

5
Cerebrospinal Fluid Metabolites and Multiple Sclerosis: Genetic Clues to Disease Risk
Genetics
Cerebrospinal Fluid Metabolites and Multiple Sclerosis: Genetic Clues to Disease Risk

22, Aug 2026

Categories:
Genetics
How Glatiramer Acetate Rewires B Cells to Calm Multiple Sclerosis
Genetics
How Glatiramer Acetate Rewires B Cells to Calm Multiple Sclerosis

01, Sep 2025

Ocrelizumab and B Cells: How MS Therapy Reshapes the Immune Landscape
Genetics
Ocrelizumab and B Cells: How MS Therapy Reshapes the Immune Landscape

01, Sep 2025

Ocrelizumab’s Hidden Side: How MS Therapy Shapes Memory CD8+ T Cells and Infection Risk
Genetics
Ocrelizumab’s Hidden Side: How MS Therapy Shapes Memory CD8+ T Cells and Infection Risk

01, Sep 2025

BAFF as a Crystal Ball: Predicting Immune Risks in MS Patients on Ocrelizumab
Genetics
BAFF as a Crystal Ball: Predicting Immune Risks in MS Patients on Ocrelizumab

04, Sep 2025